Overview
Status
Active
Registry date
2015-01-14
Share capital
5,000.00 PLN
Registered address
ul. Michała Tokarzewskiego 14, 61-695 Poznań, Poland
Email
Electronic delivery address
AE:PL-23960-83451-RIJFH-12
Financials
Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.
Revenue history
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 81 days late).
- 202507/07/2026
- 202424/03/2025
- 202317/06/2024
- 202229/06/2023
- 202104/10/2022
- 202030/09/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Anna Maria Skorupska – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Artur Piotr Skorupskiage 55 | 99 | $1,337.12 | 99% |
Others | 1 | $13.51 | 1% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Delpharm PoznańS.A. | $110,900,246.81 | delpharm.com | ||
| Poznańskie Zakłady Zielarskie HerbapolS.A. | $31,668,225.77 | herbapol.poznan.pl | ||
| Curtis Health CapsS.A. | $30,831,117.38 | chc.com.pl | ||
| Przedsiębiorstwo Farmaceutyczne Farmapolsp. z o.o. | $21,462,728.43 | farmapol.pl | ||
| Natur DayS.A. | $680,635.59 | naturday.pl | ||
| Biotriosp. z o.o. | $453,662.22 | biotrio.pl | ||
| Nature's Voicesp. z o.o. | $181,977.76 | naturesvoice.eu | ||
| Pexon Polandsp. z o.o. | $122,615.96 | pexon.pl | ||
| Bioresearch PharmaS.A. | $21,432.15 | bioresearchpharma.com | ||
| Grupa FinepharmS.A. | – | finepharm.pl |
FAQ
The main business activity of As-Pharm focuses on manufacture of basic pharmaceutical products.
The company was registered in the Polish National Court Register (KRS) on January 14, 2015.
The headquarters is located at: ul. Michała Tokarzewskiego 14, 61-695 Poznań.
The management board consists of: Anna Maria Skorupska (President of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
Last updated: 2026-07-09